Lombard Medical, Inc. announced positive long-term data for its Aorfix™ endovascular stent graft system providing confirmation of sustained performance in the most challenging anatomies. The data from the only IDE study to focus on high neck angulation was presented at the 43rd annual VEITHsymposium™ on November 17, 2016. Aorfix is designed for highly tortuous anatomy and is the only stent graft to hold global approvals to treat abdominal aortic aneurysms with aortic neck angles up to 90 degrees. At the fifth year, there were no type I or III endoleaks, migration was seen in 3.3% of cases, freedom from aneurysm-related mortality in patients with neck angles 60 degrees and greater was 95% and this rose to 99% in patients with neck angles less than 60 degrees.